The 20 Best Maturity Onset Diabetes of the Young Doctors Near Me in Pikesville, MD

Cristian Vilcu is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Vilcu is rated as a Distinguished provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Adrenal Gland Adenoma, and Hypothyroidism.

Dr. Maruthur has a primary care practice at the Levine Group Internal Medicine Practice at Johns Hopkins Green Spring Station. In addition to seeing patients for one-half day per week, Dr. Maruthur conducts clinical research in diabetes with an emphasis on prevention. She is especially interested in community-based approaches to improving diabetes outcomes and individualized medicine, the tailoring of preventive and treatment strategies based on an individual's biology and preferences. Dr. Maruthur also directs the JHU General Internal Medicine Fellowship. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Maruthur is rated as a Distinguished provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Low Blood Sugar, Obesity, and Gastric Bypass. Dr. Maruthur is board certified in American Board Of Internal Medicine.

Kashif Munir is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Munir is rated as a Distinguished provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Thyroid Cancer, Thyroid Storm, Pituitary Tumor, and Thyroidectomy.

Yaniv Berger is a primary care provider, practicing in Family Medicine in Baltimore, Maryland. Dr. Berger is rated as a Distinguished provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Maturity Onset Diabetes of the Young, Glucocorticoid-Remediable Aldosteronism, Hypertension, Pancreaticoduodenectomy, and Hepatectomy.

Dr. Aniket Sidhaye is an assistant professor of medicine and pediatrics at the Johns Hopkins University School of Medicine. His specific clinical interests are cystic fibrosis related endocrine disorders, type 1 diabetes mellitus particularly emerging adults with diabetes, thyroid disorders, metabolic bone disease, and management of hospitalized persons with diabetes. Dr. Sidhaye earned his M.D. from Northwestern University’s Feinberg School of Medicine. He completed his residency at Northwestern University. He performed a research fellowship in endocrinology and metabolism at Northwestern University and also performed fellowships in endocrinology and metabolism at Johns Hopkins. His research interests include CF related diabetes, bone health of CF patients after lung transplant, and the care of emerging adults with type 1 diabetes. In addition, he is a committed educator serving as an advisor in the medical school, co-director for the endocrine course for pre-clinical medical students, and program director for our endocrine fellowship. Dr. Sidhaye is rated as an Experienced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Type B Insulin Resistance Syndrome, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Paget's Disease of Bone.

Robert Roby is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Roby is rated as a Distinguished provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Maturity Onset Diabetes of the Young, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension.

Esther Krug is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Krug is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Osteoporosis, and Graves Disease.

Artit Silpasuvan is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Silpasuvan is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Familial Isolated Hyperparathyroidism, and Osteitis Fibrosa.

Henry Fein is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Fein is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Thyroid Storm, Graves Disease, Follicular Thyroid Cancer, Thyroid Cancer, and Thyroidectomy.

Paul Sack is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Sack is rated as a Distinguished provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), and Hypothyroidism.

Malek Cheikh is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Cheikh is rated as a Distinguished provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Osteoporosis, and Postmenopausal Osteoporosis.

Lina Melhem is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Melhem is rated as a Distinguished provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Juvenile Primary Osteoporosis, Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), and Hypothyroidism.

Rozalina Mccoy is an Endocrinologist practicing medicine in Baltimore, Maryland. She has been practicing medicine for over 17 years. Dr. Mccoy is rated as a Distinguished provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Diabetic Hyperglycemic Hyperosmolar Syndrome.

David Madoff is an Endocrinologist practicing medicine in Pikesville, Maryland. Dr. Madoff is rated as an Experienced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Osteoporosis, Postmenopausal Osteoporosis, Type 2 Diabetes (T2D), and Diabetic Neuropathy.

Sally Pinkstaff is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Pinkstaff is rated as an Experienced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Osteoporosis, Postmenopausal Osteoporosis, and Hypothyroidism.

Colleen Leavitt, M.D., practices internal medicine and pediatrics at Johns Hopkins Community Physicians. She received her medical degree and completed her residency in medicine & pediatrics at Loyola University School of Medicine. Dr. Leavitt is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension. Dr. Leavitt is board certified in American Board Of Pediatrics and American Board Of Internal Medicine.

Dr. Rita Kalyani is a Professor of Medicine at Johns Hopkins School of Medicine. She graduated with an undergraduate degree from Harvard College and completed her medical degree, residency, and fellowship at Johns Hopkins. She also obtained a Masters in Health Science degree in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. As a NIH-funded clinician scientist, Dr. Kalyani has authored over 175 peer-reviewed publications and built a research program focused on understanding the factors leading to development of diabetes complications, particularly in high-risk populations. She has conducted epidemiological and patient-oriented research that has led to fundamental discoveries regarding the development of skeletal muscle loss, physical disability, and frailty in diabetes. She has also spearheaded studies investigating sex differences in cardiovascular disease and diabetes which have influenced primary prevention guidelines. Dr. Kalyani launched the Diabetes Management Service for Johns Hopkins’ Total Pancreatectomy Islet Auto Transplant Program in 2011. She is the co-founder of the Johns Hopkins Diabetes POC-IT Guide for healthcare professionals. She is also the founder and past Editor-in-Chief of the Johns Hopkins Patient Website to Diabetes. Dr. Kalyani has been the Chief Scientific and Medical Officer of the American Diabetes Association since 2025. She previously served as President of Medicine & Science on the ADA's National Board of Directors. She continues to have a clinical practice as an adult endocrinologist. Dr. Kalyani is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Seasonal Affective Disorder (SAD), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Pancreatectomy, and Islet Cell Transplantation.

Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young. Dr. Donner is board certified in American Board Of Internal Medicine.

Todd T. Brown, MD, PhD is a clinical investigator who focuses on body composition, metabolic, and skeletal abnormalities observed in people with HIV, particularly as related to aging. Through translational investigation, epidemiologic studies, and clinical trials, he has been interested in understanding the pathogenesis of glucose disorders, fat changes, hormonal dysregulation, and osteoporosis in people with HIV, the consequences of these conditions (eg cardiovascular disease, frailty), and their optimal evaluation and management. Dr. Brown is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Low Blood Sugar, Osteoporosis, Malnutrition, Gastric Bypass, and Gastrostomy.

Dr. Mathioudakis, an endocrinologist and researcher, has a strong focus on diabetes management and patient care, recognized through awards like the Baltimore Top Doc. He has contributed significantly to diabetes research, authoring over 150 publications and participating in the development of consensus guidelines in the field. His studies have offered valuable insights into using health informatics for diabetes prevention and management. After graduating from the Johns Hopkins University School of Medicine and completing his training in Internal Medicine and a fellowship in Endocrinology, Diabetes, & Metabolism, Dr. Mathioudakis joined the faculty in the Division of Endocrinology, Diabetes & Metabolism in 2012. He earned a Master of Health Science in clinical investigation in 2015 and was the Clinical Director of the Division of Endocrinology from 2016 to 2021. Currently, he co-directs the Baltimore Metropolitan Diabetes Regional Partnership, focusing on improving access to diabetes prevention and management programs. As a physician-scientist, Dr. Mathioudakis leads multiple research studies funded by the NIH, private philanthropic organizations (Helmsley Charitable Trust), non-profit organizations (Breakthrough T1D), and industry. His research focuses on the effectiveness of automated diabetes prevention programs and strategies to reduce racial disparities in diabetes technology access. He also collaborates nationally to enhance care for people with type 1 diabetes. Holding a joint appointment in the Division of Biomedical Informatics and Data Science, Dr. Mathioudakis integrates machine learning and AI in diabetes research. He has served on the national Epic Endocrinology Specialty Steering Board and chaired the Type 2 Diabetes Prognostics Working Group for the Precision Medicine Diabetes Initiative. Committed to education, he frequently lectures on endocrinology, epidemiology, and health informatics. Dr. Mathioudakis is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Low Blood Sugar, Diabetic Ketoacidosis, and Pancreaticoduodenectomy.